Today: 14 November 2025
Subscribe
Browse Tag

investor news

Bristol Myers Squibb (BMY) Shares Slide as Milvexian Heart Trial Halted After Interim Review – What Investors Need to Know Today (14 November 2025)

Bristol Myers Squibb (BMY) Shares Slide as Milvexian Heart Trial Halted After Interim Review – What Investors Need to Know Today (14 November 2025)

Bristol Myers Squibb and Johnson & Johnson end a key Phase 3 heart study for milvexian, sending BMY stock lower even as the pharma giant leans on a strong growth portfolio and fresh financing firepower. Bristol-Myers Squibb Company (NYSE: BMY) is back in the spotlight today after the company and its partner Johnson & Johnson announced they will discontinue a major Phase 3 trial of their experimental blood thinner milvexian in acute coronary syndrome (ACS). The decision, based on a scheduled interim review showing the study was unlikely to hit its main goal, has pushed BMY shares lower and reignited
14 November 2025
 ·  ·  ·  ·  ·  · 
Motorsport Games (MSGM) Rockets Premarket on Q3 Profit; Terminates $12M Related‑Party Credit Line as Le Mans Ultimate Momentum Builds — Nov. 7, 2025

Motorsport Games (MSGM) News Today — Nov 12, 2025: Fresh Le Mans Ultimate Patch Lands Ahead of This Weekend’s Team Events as Investors Weigh Q3 Profit

Date: Wednesday, November 12, 2025Ticker: NASDAQ: MSGM Motorsport Games Inc. (MSGM) didn’t issue a new corporate press release or SEC filing today, but there was movement on the product side: a small, same‑day update for its flagship sim Le Mans Ultimate (LMU) hit Steam, part of the company’s ongoing cadence of fixes and feature rollouts following last week’s earnings. According to SteamDB, a new LMU build (ID 20678259) was published on November 12 at roughly 10:20 UTC. While formal patch notes weren’t attached to the build log, the official LMU X account flagged a brief maintenance window and highlighted minor
12 November 2025
 ·  ·  ·  · 
JD.L: JD Sports Edges Higher as Buyback Continues — All the News Investors Need on 11 November 2025

JD.L: JD Sports Edges Higher as Buyback Continues — All the News Investors Need on 11 November 2025

Date: 11 November 2025 JD Sports Fashion (LSE: JD., ticker JD.L) traded modestly higher today as the retailer reported another daily share repurchase under its £100m buyback. Here’s today’s price action, the fresh RNS, and the next catalysts investors should watch Quick take JD.L share price snapshot (11 Nov 2025) JD Sports shares ticked higher in London, with last trade c. 85p, a day range of 84.06p–85.60p, and a 52‑week range of 61.04p–122.55p. Previous close was 84.76p; today’s open 85.30p. These figures position the stock near the lower third of its 12‑month range despite today’s uptick. Reuters Today’s JD Sports
11 November 2025
 ·  ·  ·  · 
Aspire Biopharma (ASBP) Whipsaws on Heavy Volume Today as Investors Eye Reverse‑Split Authority and Nasdaq Compliance — Nov. 11, 2025

Aspire Biopharma (ASBP) Whipsaws on Heavy Volume Today as Investors Eye Reverse‑Split Authority and Nasdaq Compliance — Nov. 11, 2025

What moved ASBP today (Nov. 11) Trading in Aspire Biopharma swung sharply. A pre‑market “health‑care movers” screen showed ASBP briefly up more than 30%, before regular‑session selling pulled shares lower on very heavy volume. Mid‑session, ASBP was down roughly 20–25% versus Monday’s close, with an exceptionally wide intraday range—characteristic of micro‑cap names facing near‑term listing and financing milestones. Benzinga While price action is noisy, there were no fresh corporate announcements today. The latest company communication remains last week’s trade‑show recap from CPHI Frankfurt, where Aspire says it held 16 formal meetings and multiple informal conversations with global pharmas regarding potential
11 November 2025
 ·  ·  ·  ·  · 
Canada Goose (GOOS): Fresh 13F Moves, Buyback Launch, and New Analyst Targets — What Investors Need to Know Today (Nov. 11, 2025)

Canada Goose (GOOS): Fresh 13F Moves, Buyback Launch, and New Analyst Targets — What Investors Need to Know Today (Nov. 11, 2025)

What changed today (Nov. 11, 2025) The most recent developments as of Tuesday, Nov. 11 revolve around post‑earnings positioning and new sell‑side targets. Barclays cut its 12‑month price target to $11 while maintaining Equal‑Weight, citing a more cautious view after last week’s results. UBS raised its target to $12 but stayed Neutral, reflecting improving momentum but limited near‑term conviction. GuruFocus+1 Meanwhile, the company’s renewed normal course issuer bid (NCIB) formally began on Nov. 10, enabling buybacks of up to 4.58M shares over the next 12 months—about 10% of the public float—potentially providing a modest support to per‑share metrics during volatility.
11 November 2025
 ·  ·  ·  ·  · 
Vivakor (VIVK) Executes $23M LPG Trade Under $40M Credit Facility — What It Means for Investors Today (Nov. 10, 2025)

Vivakor (VIVK) Executes $23M LPG Trade Under $40M Credit Facility — What It Means for Investors Today (Nov. 10, 2025)

What happened today (Nov. 10, 2025) Vivakor, Inc. (Nasdaq: VIVK) announced that its trading arm, Vivakor Supply & Trading, has kicked off its first LPG transaction—approximately $23 million in contract value—under the company’s $40 million intermediation credit facility. Management framed the deal as a “significant operational milestone” that expands the platform into broader petroleum commodities while relying on Vivakor’s logistics and midstream footprint for transportation, gathering and execution. GlobeNewswire Why it matters How today’s news fits the recent timeline By the numbers Market reaction & read-through Shares of VIVK are higher today on the announcement. The investment takeaway is less
10 November 2025
 ·  ·  ·  ·  · 
Block (XYZ) Stock Slides After Q3 Miss, But Guidance Ticks Higher — What Investors Need to Know Today (Nov 6, 2025)

Block (XYZ) Stock Slides After Q3 Miss, But Guidance Ticks Higher — What Investors Need to Know Today (Nov 6, 2025)

Byline: Nov 6, 2025 — Daily coverage of XYZ stock news and catalysts for Google News & Discover. Lede Block, Inc. (NYSE: XYZ) released third‑quarter results after the bell today, missing Wall Street estimates on both revenue and adjusted EPS and sending shares down roughly 10%–13% in after‑hours trading. Management, however, raised full‑year 2025 gross profit guidance—a key input many investors track—setting up a split reaction between headline misses and improved outlook. Reuters+1 What happened today Key operating takeaways While topline and EPS missed, the company highlighted healthy ecosystem trends: MarketWatch also noted investor focus on limited flow‑through: despite a
6 November 2025
 ·  ·  ·  ·  · 
DroneShield Stock Skyrockets 40%: What’s Behind the Surge and What’s Next?

DroneShield (ASX:DRO) tumbles as 31.16m new shares hit the market after option vesting — what today’s filings mean for investors (Nov 6, 2025)

Key points What happened today (Nov 6) DroneShield shares continued to feel the aftershocks of mid‑week filings. European quotations on Tradegate showed the stock lower by about 8.3% to €2.04 at 11:30 CET on Thursday, extending Wednesday’s weakness on the ASX. FinanzNachrichten.de The slide follows confirmation that 31,161,833 new DroneShield shares were approved for quotation on 5 November. The ASX Appendix 2A filing makes clear these shares arose from options/performance rights being exercised/converted, with nil cash consideration. In other words, this was dilution from award vesting, not a fresh capital raising. Company Announcements+2Company Announcements+2 A companion Cleansing Notice—the standard disclosure
6 November 2025
 ·  ·  ·  · 
Nuclear SPAC Stock Skyrockets: Terrestrial Energy’s SPAC Deal Ignites Investor Frenzy

Nuclear SPAC Stock Skyrockets: Terrestrial Energy’s SPAC Deal Ignites Investor Frenzy

Terrestrial Energy is a Generation-IV nuclear developer known for its IMSR technology ts2.tech businesswire.com. The IMSR is a modular molten-salt reactor that uses low-enriched uranium; it is inherently safe thanks to its fuel salt and temperature control design ts2.tech globenewswire.com. Terrestrial has been building regulatory momentum: besides the recent NRC ruling, Canada’s regulator completed a positive Vendor Design Review in 2023, finding “no fundamental barriers to licensing” the IMSR for commercial use globenewswire.com. The company plans to build first IMSR plants in the early 2030s and markets them not only for electricity but also high-temperature industrial heat (data centers, chemical
20 October 2025
 ·  ·  ·  ·  · 
Humana (HUM) Stock Skyrockets on Medicare News – What Investors Must Know Today

Humana Stock Skyrockets as Medicare Advantage News Ignites Rally

Stock Performance and Recent Moves On Oct. 3, 2025 Humana’s stock surged sharply – closing up ~10.6% after a late afternoon rally stockstory.org. Intraday gains peaked around +11.9% as news broke that Humana’s Medicare Advantage star ratings and plan enhancements were better than feared. (By comparison, the prior day Humana had already jumped ~6% on Oct. 2 when preliminary MA star ratings were disclosed stockstotrade.com.) The Oct. 3 close near $283.72 was well above the ~$256 level of just days earlier, reflecting strong investor enthusiasm. Trading volume was heavy, and market commentary noted that moves of this size are rare
3 October 2025
 ·  ·  ·  ·  · 
Quantum Leap: D-Wave (QBTS) Stock Skyrockets 2000% Amid Fed Rate Cuts and AI-Fueled Quantum Breakthroughs

Quantum Leap for Investors: D-Wave (QBTS) Stock Rockets Amid Breakthroughs, Big Cash & Booming Demand

Stock Performance on Oct 2, 2025 On Oct 2, 2025 (Thursday), D-Wave’s share price climbed sharply. It opened around $26.20 and hit a high of $28.58 before closing at $28.57, up +11.47% from the prior day investing.com. The trading volume (~19.78M) was well above recent daily averages, indicating robust investor interest. This move follows gains on Oct 1 (+3.72%) from a $25.63 close investing.com, and a period of volatile up-and-down swings in late September. Notably, the stock’s 50-day moving average (~$18.72) is now well below the current price marketbeat.com, signaling strong momentum. By Oct 2, QBTS was trading near its 12‑month high (~$29.18) marketbeat.com, after
2 October 2025
 ·  ·  ·  ·  ·  · 
Go toTop